Dr. Carr is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3400 Civic Center Blvd
2nd Floor, Suite 310 S
Philadelphia, PA 19106Phone+1 215-662-2300Fax+1 215-614-0418- Is this information wrong?
Summary
- Dr. Molly Carr is an endocrinologist in Philadelphia, PA and is affiliated with Hospital of the University of Pennsylvania. She received her medical degree from Columbia University College of Physicians & Surgeons and has been in practice 23 years. She specializes in diabetes, lipid metabolism, and obesity and is experienced in non-alcoholic fatty liver disease, obesity and obesity-related disorders, endocrinology, hyperlipidemia, and adipose tissue.
Clinical Expertise
- Non-alcoholic fatty liver disease, Diabetes mellitus, Obesity and obesity-related disorders, Lipid metabolism disorders, Endocrinology, Hyperlipidemia, Medical weight loss, Adipose Tissue, Experimental Diabetes Mellitus, Nash, Prospective Studies
Education & Training
- University of WashingtonFellowship, Endocrinology, Diabetes, and Metabolism, 1997 - 2000
- University of WashingtonResidency, Internal Medicine, 1994 - 1997
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1994
Certifications & Licensure
- PA State Medical License 2008 - 2022
- IL State Medical License 2004 - 2008
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 30 citationsImpact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Cont...Julio Rosenstock, Antonio Nino, Joseph Soffer, Lois M. Erskine, Andre Acusta, Jo F. Dole, Molly C. Carr, Jason M. Mallory, Philip Home> ;Diabetes Care. 2020 Jul 21
- 2 citationsWeekly glucagon-like peptide-1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomize...Antonio Nino, Inaha Okuda, Timothy Wilson, Lynn Yue, Hiromu Nakajima, Maho Tsuboi, Molly C. Carr, Yutaka Seino> ;Journal of Diabetes Investigation. 2018 May 1
- 14 citationsThree-year data from 5 HARMONY phase 3 clinical trials of albiglutide in type 2 diabetes mellitus: Long-term efficacy with or without rescue therapyPhilip Home, Bo Ahrén, Jane E.B. Reusch, Marc Rendell, Peter N. Weissman, Deborah T. Cirkel, Diane Miller, Philip D. Ambery, Molly C. Carr, Michael A. Nauck> ;Diabetes Research and Clinical Practice. 2017 Sep 1
- Join now to see all
Press Mentions
- These Are the Bedside Concerts Comforting Virus PatientsMay 4th, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: